Potentiation of anti-tumor immune effects by PARP Inhibitors

被引：0

作者：

Chabanon, R. ^{[1
]}

Muirhead, G. ^{[2
]}

Krastev, D. ^{[2
]}

Adam, J. ^{[3
]}

Garrido, M. ^{[4
]}

Morel, D. ^{[1
]}

Dorvault, N. ^{[1
]}

Pettitt, S. ^{[2
]}

Tutt, A. N. J. ^{[5
]}

Marabelle, A. ^{[6
]}

Soria, J. C. ^{[6
]}

Lord, C. J. ^{[2
,5
]}

Postel-Vinay, S. ^{[7
]}

机构：

[1] Gustave Roussy, U981 Inserm Atip Avenir, Villejuif, France

[2] Inst Canc Res, Cruk Gene Funct Lab, London, England

[3] Gustave Roussy, Dept Pathol, Villejuif, France

[4] Gustave Roussy, U981 Inserm, Villejuif, France

[5] Inst Canc Res, Breast Canc Now Res Unit, London, England

[6] Gustave Roussy, Drug Dev Dept, Villejuif, France

[7] Gustave Roussy, Drug Dev Dept, Inserm U981, Villejuif, France

来源：

RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-0258

引用

页码：S132 / S132

页数：1

共 50 条

[21] Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies
Zeinab Abbasi-Radmoghaddam
Siavash Riahi
Sajjad Gharaghani
Mohammad Mohammadi-Khanaposhtanai
[J]. Molecular Diversity, 2021, 25 : 263 - 277
[22] Tumor antigenic peptide vaccine enhances anti-tumor effects of Immune checkpoint inhibitors against refractory cancers.
Ueda, Shohei
Irie, Atsushi
Senju, Satoru
Ito, Koyu
Hamana, Hiroshi
Ogasawara, Koetsu
Kishi, Hiroyuki
Eto, Masatoshi
Nishimura, Yasuharu
[J]. CANCER SCIENCE, 2021, 112 : 405 - 405
[23] Tumor associated antigen vaccine enhances anti-tumor effects of immune checkpoint inhibitors against refractory cancers.
Ueda, Shohei
Ushijima, Miho
Irie, Atsushi
Senju, Satoru
Ito, Koyu
Hamana, Hiroshi
Kishi, Hiroyuki
Ogasawara, Koetsu
Udaka, Keiko
Eto, Masatoshi
Nishimura, Yasuharu
[J]. CANCER SCIENCE, 2023, 114 : 282 - 282
[24] Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors
Kinoshita, Tomonari
Abu Sayem, Mohammad
Yaguchi, Tomonori
Kharma, Budiman
Morii, Kenji
Kato, Daiki
Ohta, Shigeki
Mashima, Yukihiko
Asamura, Hisao
Kawakami, Yutaka
[J]. CANCER SCIENCE, 2021, 112 (04) : 1390 - 1401
[25] Effects of BCR-ABL Inhibitors on Anti-Tumor Immunity
Krusch, M.
Salih, H. R.
[J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (34) : 5174 - 5184
[26] Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors
Zhang, Lin
Zhou, Chao
Zhang, Songou
Chen, Xiaozhen
Liu, Jian
Xu, Fangming
Liang, Wenqing
[J]. FRONTIERS IN ONCOLOGY, 2022, 12
[27] POTENTIATION OF ANTI-TUMOR EFFECT OF VIRUS-INDUCED INTERFERON BY MOUSE IMMUNE INTERFERON PREPARATIONS
FLEISCHMANN, WR
KLEYN, KM
BARON, S
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1980, 65 (05) : 963 - 966
[28] POTENTIATION OF CHLORAMBUCIL ANTI-TUMOR ACTIVITY BY CENTROPHENOXINE INVIVO
BROPHY, GT
SLADEK, NE
[J]. PHARMACOLOGIST, 1978, 20 (03): : 229 - 229
[29] Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors (vol 22, pg 194, 2016)
Du, Yi
Yamaguchi, Hirohito
Wei, Yongkun
Hsu, Jennifer L.
Wang, Hung-Ling
Hsu, Yi-Hsin
Lin, Wan-Chi
Yu, Wen-Hsuan
Leonard, Paul G.
Lee, Gilbert R.
Chen, Mei-Kuang
Nakai, Katsuya
Hsu, Ming-Chuan
Chen, Chun-Te
Sun, Ye
Wu, Yun
Chang, Wei-Chao
Huang, Wen-Chien
Liu, Chien-Liang
Chang, Yuan-Ching
Chen, Chung-Hsuan
Park, Morag
Jones, Philip
Hortobagyi, Gabriel N.
Hung, Mien-Chie
[J]. NATURE MEDICINE, 2016, 22 (10) : 1192 - 1192
[30] Anti-Tigit induces T cell mediated anti-tumor immune response and combines with immune checkpoint inhibitors to enhance strong and long term anti-tumor immunity
Srivastava, Minu K.
Yun, Rui
Mayes, Erin
Yu, Janice
Jie, Hyun-Bae
Axelrod, Fumiko
Xie, Ming-Hong
Monteon, Jorge
Lam, Andrew
Ji, May
Liu, Yuwang
Lewicki, John
Hoey, Tim
Gurney, Austin
Park, Angie Inkyung
[J]. CANCER RESEARCH, 2017, 77

← 1 2 3 4 5 →